Search Results for “” – Page 3 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes Economics

32 Publications found

Noninvasive Cardiac Testing vs Clinical Evaluation Alone in Acute Chest Pain: A Secondary Analysis of the ROMICAT-II Randomized Clinical Trial.

b

JAMA internal medicine

February 1, 2018

p Cardiovascular Disease

c Change patient management Clinical outcomes Economics Operational efficiencies RCT
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study.

b

JCO precision oncology

January 1, 2018

p Cancer

c Change patient management Clinical outcomes Economics Observational
Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial.

b

AIDS (London, England)

July 17, 2017

p HIV POCT

c Change patient management Clinical outcomes Economics Highlighted RCT
Cost effectiveness of high-sensitivity troponin compared to conventional troponin among patients presenting with undifferentiated chest pain: A trial based analysis.

b

International journal of cardiology

July 1, 2017

p Cardiovascular Disease

c Clinical outcomes Economics RCT
A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs.

b

Journal of oncology practice

February 1, 2017

p Cancer

c Change patient management Clinical outcomes Economics Highlighted Observational
Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia.

b

Diagnostic microbiology and infectious disease

January 1, 2016

p MALDI-TOF MS For Microorganism Identification

c Change patient management Clinical outcomes Economics Observational
Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa.

b

Nature

December 3, 2015

p HIV POCT

c Change patient management Clinical outcomes Economics Highlighted Meta-analysis Review
Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.

b

Lung cancer (Amsterdam, Netherlands)

May 1, 2015

p Cancer

c Clinical outcomes Economics Model
Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial.

b

Gut

June 1, 2014

p Therapeutic drug monitoring

c Clinical outcomes Economics RCT
A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis.

b

Lung cancer (Amsterdam, Netherlands)

December 1, 2013

p Cancer

c Clinical outcomes Economics Model